✦ LIBER ✦

Fixed dose-rate infusion of gemcitabine in combination with cisplatin and UFT in advanced carcinoma of the pancreas

✍ Scribed by J. Feliu; J. García Sáenz; A. Rodríguez Jaráiz; C. Castañón; M. Cruz; E. Fonseca; M. Lomas; J. Castro; C. Jara; E. Casado; A. León; M. González Barón

Publisher: Springer
Year: 2006
Tongue: English
Weight: 225 KB
Volume: 58
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-005-0167-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fixed-dose-rate gemcitabine combined wit

Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas

✍ David Goldstein; M. Corona Gainford; Chris Brown; Niall Tebbutt; Stephen P. Ackl 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 268 KB

Fixed dose-rate gemcitabine infusion as

Fixed dose-rate gemcitabine infusion as first-line treatment for advanced-stage carcinoma of the pancreas and biliary tree

✍ Alain Gelibter; Paola Malaguti; Serena Di Cosimo; Emilio Bria; Enzo Maria Rugger 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

Pharmacokinetic study of gemcitabine, gi

Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer

✍ Orazio Caffo; Stefania Fallani; Elena Marangon; Stefania Nobili; Maria Iris Cass 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 171 KB

Dose-escalation study of fixed-dose rate

Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignancies

✍ Steven Attia; Sherry Morgan-Meadows; Kyle D. Holen; Howard H. Bailey; Jens C. Ei 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 380 KB

Phase II study of a fixed dose-rate infu

Phase II study of a fixed dose-rate infusion of gemcitabine associated with docetaxel in advanced non-small-cell lung carcinoma

✍ J. De Castro; A. Lorenzo; S. Morales; J. Belón; J. Dorta; J. Lizón; C. Madroñal; 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 183 KB

Phase II study of a fixed dose-rate infu

Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer

✍ J. Feliu; P. Borrega; A. León; L. López-Gómez; M. López; J. Castro; C. Belda-Ini 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 287 KB